General Pharmacology: The Vascular System
Volume 27, Issue 8, December 1996, Pages 1283-1291
ReviewThe P-glycoprotein multidrug transporter
References (157)
Clinical significance of P-glycoprotein in multidrug resistance malignancies
Blood
(1993)- et al.
Multidrug resistance in the laboratory and clinic
Adv. Clin. Chem.
(1994) - et al.
Synthetic and natural opiates interact with P-glycoprotein in multidrug resistant cells
J. Biol. Chem.
(1993) - et al.
Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis
Blood
(1992) - et al.
Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells
Cell
(1991) - et al.
Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes
Blood
(1992) - et al.
Internal duplication and homology with bacterial transport proteins in the mdrl(P-glycoprotein) gene from multidrug-resistant human cells
Cell
(1986) - et al.
Genomic organisation of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins
J. Biol. Chem.
(1990) - et al.
Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells
J. Biol. Chem.
(1990) - et al.
NF-IL6, a member of the C/EBP family of transcription factors, binds and transactivates the human MDR1 gene promoter
J. Biol. Chem.
(1994)
SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity
J. Biol. Chem.
(1993)
A signal transduction pathway for activation of the mdrl promoter involves the proto-oncogene c-raf kinase
J. Biol. Chem.
(1993)
Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters
J. Biol. Chem.
(1992)
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance
Biochem. Pharmacol.
(1992)
Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells
Biochim. Biophys. Acta
(1973)
Detection of P-glycoprotein activity in normal and leukemic CD34 positive cells
Leukemia Res.
(1993)
Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes
FEBS Lett.
(1993)
Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells
Biochem. Pharmacol.
(1995)
Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum
Cell
(1989)
Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications
Blood
(1993)
A Y-box consensus is required for basal expression of the human multidrug resistance (mdrl) gene
J. Biol. Chem.
(1993)
P-glycoprotein expression in human plasma cell myeloma: Correlation with prior chemotherapy
Blood
(1993)
Rational design and preclinical pharmacology of drugs for reversing multidrug resistance
Biochem. Pharmacol.
(1992)
Is the multidrug transporter a flippase?
Trends Biochem. Sci.
(1992)
Selective drug transport and P-glycoprotein activity in an in vitro blood-brain barrier model
Tox. In Vitro
(1995)
Heat-shock responsive elements in the induction of the multidrug resistance gene (MDR1)
FEBS Lett.
(1992)
Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK 16 monoclonal antibody and AHC-52
Biochem. Pharmacol.
(1994)
The direct activation of human multidrug resistance gene (MDR1) by anticancer agents
Biochem. Biophys. Res. Commun.
(1989)
The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P-glycoprotein function
FEBS Lett.
(1994)
Multidrug resistance (mdr 1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity
Blood
(1991)
The multidrug resistance (mdrl) gene product functions as an ATP channel
Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis
Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer
Cancer Res.
(1994)
The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus
Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus
Mol. Reprod. Dev.
(1990)
Discrete mutations introduced in the predicted nucleotide-binding sites of the mdrl gene abolish its ability to confer multidrug resistance
Mol. Cell. Biol.
(1989)
Expression of a drug resistance gene in human neuroblastoma cellines: modulation by retinoic acid-induced differentiation
Mol. Cell. Biol.
(1989)
Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate
Biochemistry
(1992)
Differential modulation of P-glycoprotein transport by protein kinase inhibition
Biochemistry
(1993)
Continued expression of Vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase
Cancer Res.
(1982)
Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic and cytogenetic studies
Cancer Res.
(1970)
Correlation of MDR1 gene expression with chemotherapy in neuroblastoma
J. Natl. Cancer Inst.
(1989)
Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics
J. Natl. Cancer Inst.
(1988)
Transformation of rat liver epithelial cells with v-H-ras or v-raf causes expression of MDR-1, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals
Carcinogenesis
(1988)
Localization of the human multiple drug resistance gene, MDR1, to 7q21.1
J. Hum. Genet.
(1987)
Regulation by phorbol ester and protein kinase C inhibitors and by a protein phosphatase inhibitor (okadaic acid) of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cell
Mol. Pharmacol.
(1992)
Immunohisto-chemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood
J. Clin. Oncol.
(1990)
Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists
Oncology Res.
(1992)
Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs
J. Natl. Cancer Inst.
(1993)
Prevalence of multidrug resistance related to activation of the mdrl gene in human sarcoma mutants derived by single-step doxorubicin selection
Cancer Res.
(1994)
Cited by (218)
A proof of concept using the Ussing chamber methodology to study pediatric intestinal drug transport and age-dependent differences in absorption
2022, Clinical and Translational SciencePotential Dexamethasone–Direct Oral Anticoagulant Drug Interaction: Is This a Concern in COVID?
2022, Annals of PharmacotherapyComparative in silico prediction of P-glycoprotein-mediated transport for 2010–2020 US FDA-approved drugs using six Web-tools
2021, Biopharmaceutics and Drug Disposition
Copyright © 1996 Published by Elsevier Inc.